Patent · US Active

Methods for manufacturing an antifungal agent

US8981055B2 · kind B2 · utility

0Cited by

2References

14Claims

0Family size

Assignee

Xellia Pharmaceuticals ApS · DK

Inventors

Solvi Gunnes · Sandvika, NO
Harald Halvorsen · Oslo, NO

Key dates

Filing date	Mar 26, 2012
Grant date	Mar 17, 2015
Priority date	—
Expiry date	Apr 3, 2032

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61K38/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention relates to an improved process for the preparation of Micafungin.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.